{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:39:53Z","timestamp":1788910793871,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jpba.2018.12.018","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T11:03:45Z","timestamp":1549019025000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Ex-vivo intestinal absorption study of boswellic acid, cyclodextrin complexes and poloxamer solid dispersions using everted gut sac technique"],"prefix":"10.1016","volume":"167","author":[{"given":"Amruta","family":"Tambe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyankai","family":"Mokashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Pandita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2018.12.018_bib0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1039\/B809437N","article-title":"Boswellic acids: a group of medicinally important compounds","volume":"26","author":"Shah","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jpba.2018.12.018_bib0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1476-5381.1996.tb15235.x","article-title":"Acetyl-11-keto-\u03b2-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity","volume":"117","author":"Sailer","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpba.2018.12.018_bib0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1078\/0944-7113-00290","article-title":"Pharmacokinetic study of 11-Keto beta-Boswellic acid","volume":"11","author":"Sharma","year":"2004","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jpba.2018.12.018_bib0020","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1177\/0091270011422811","article-title":"Increased bioavailability of 11-keto-\u03b2-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: modeling and simulation considerations for evaluating drug exposures","volume":"52","author":"Skarke","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2018.12.018_bib0025","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1055\/s-2004-835844","article-title":"Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers","volume":"70","author":"Sterk","year":"2004","journal-title":"Planta Med."},{"key":"10.1016\/j.jpba.2018.12.018_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejps.2008.10.005","article-title":"Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2","volume":"36","author":"Kr\u00fcger","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2018.12.018_bib0035","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/jphp.12478","article-title":"Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir","volume":"68","author":"Miller","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jpba.2018.12.018_bib0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.molstruc.2017.10.061","article-title":"Encapsulation of boswellic acid with \u03b2- and Hydroxypropyl-\u03b2-Cyclodextrin: synthesis, characterization, in vitro drug release and molecular modelling studies","volume":"1154","author":"Amruta","year":"2018","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jpba.2018.12.018_bib0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jddst.2017.11.025","article-title":"Enhanced solubility and drug release profile of boswellic acid using a poloxamer-based solid dispersion technique","volume":"44","author":"Tambe","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jpba.2018.12.018_bib0050","first-page":"405","article-title":"Syntheses of new cyclodextrin complexes with oleanolic and ursolic acids","volume":"17","author":"Cerga","year":"2011","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.jpba.2018.12.018_bib0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.foodchem.2016.03.122","article-title":"Increasing solubility of red bell pepper carotenoids by complexation with 2-hydroxypropyl-??-cyclodextrin","volume":"208","author":"De Lima Petito","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/j.jpba.2018.12.018_bib0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0031-6865(99)00063-1","article-title":"Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with \u03b2-cyclodextrin","volume":"74","author":"\u00d6zkan","year":"2000","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.jpba.2018.12.018_bib0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/2231-4040.154542","article-title":"Preparation and characterization of standardized pomegranate extract-phospholipid complex as an effective drug delivery tool","volume":"6","author":"Vora","year":"2015","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.jpba.2018.12.018_bib0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2010.10.017","article-title":"Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion","volume":"403","author":"Li","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2018.12.018_bib0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1365\/s10337-004-0417-3","article-title":"High-performance liquid chromatographic analysis of triterpenoids in commercial frankincense","volume":"60","author":"Mathe","year":"2004","journal-title":"Chromatographia."},{"key":"10.1016\/j.jpba.2018.12.018_bib0080","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1055\/s-0030-1250612","article-title":"Complete structural assignment of serratol, a cembrane-type diterpene from Boswellia serrata, and evaluation of its antiprotozoal activity","volume":"77","author":"Schmidt","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.jpba.2018.12.018_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21101329","article-title":"Quantitative determination of 3-O-Acetyl-11-Keto-Boswellic acid (AKBA) and other boswellic acids in boswellia sacra flueck (syn. B. Carteri Birdw) and Boswellia serrata roxb","volume":"21","author":"Mannino","year":"2016","journal-title":"Molecules."},{"key":"10.1016\/j.jpba.2018.12.018_bib0090","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jpba.2011.07.026","article-title":"Determination of major boswellic acids in plasma by high-pressure liquid chromatography\/mass spectrometry","volume":"56","author":"Gerbeth","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.12.018_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/374678","article-title":"Comparative phytochemical analyses of resins of Boswellia species (B. Papyrifera (Del.) Hochst., B. Neglecta S. Moore, and B. Rivae Engl.) from northwestern, southern, and Southeastern Ethiopia","volume":"2014","author":"Bekana","year":"2014","journal-title":"ISRN Anal. Chem."},{"key":"10.1016\/j.jpba.2018.12.018_bib0100","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1124\/dmd.107.018424","article-title":"Metabolism of boswellic acids in vitro and in vivo","volume":"36","author":"Kr\u00fcger","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2018.12.018_bib0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vascn.2011.11.001","article-title":"Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus","volume":"65","author":"Dixit","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.jpba.2018.12.018_bib0110","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/BF02993972","article-title":"Investigation of the improved effects of 2-Hydroxypropyl-13- cyclodextrin on solubility, dissolution rate, and intestinal absorptive profile of tanshinone IIA in rats","volume":"30","author":"Ling","year":"2007","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jpba.2018.12.018_bib0115","doi-asserted-by":"crossref","DOI":"10.1007\/s40005-016-0235-2","article-title":"Ex-vivo absorption study of a nanoparticle based novel drug delivery system of vitamin D 3 (Arachitol Nano TM) using everted intestinal sac technique","author":"Bothiraja","year":"2016","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jpba.2018.12.018_bib0120","first-page":"35","article-title":"Enhanced permeability of etoposide across everted sacs of rat small intestine by vitamin E-TPGS, Iran","volume":"12","author":"Parsa","year":"2013","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.jpba.2018.12.018_bib0125","doi-asserted-by":"crossref","DOI":"10.1023\/A:1012102522787","article-title":"In vitro permeability across Caco-2 cells (Colonic) can predict in vivo (small Intestinal) absorption in Man - Fact or Myth","author":"Yee","year":"1997","journal-title":"Pharm Res."},{"key":"10.1016\/j.jpba.2018.12.018_bib0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2007.07.018","article-title":"The utility of cyclodextrins for enhancing oral bioavailability","volume":"123","author":"Carrier","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2018.12.018_bib0135","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jsps.2013.03.006","article-title":"Enhanced solubility and intestinal absorption of candesartan cilexetil solid dispersions using everted rat intestinal sacs","volume":"22","author":"Gurunath","year":"2014","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.jpba.2018.12.018_bib0140","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0032-9592(03)00258-9","article-title":"Cyclodextrins and their uses: a review","volume":"39","author":"Del Valle","year":"2004","journal-title":"Process Biochem."},{"key":"10.1016\/j.jpba.2018.12.018_bib0145","first-page":"2532","article-title":"Effects of cyclodextrins on drug delivery through biological membranes","volume":"96","author":"Loftsson","year":"2007","journal-title":"Int. J. Drug Dev. Res."},{"key":"10.1016\/j.jpba.2018.12.018_bib0150","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s12272-001-2136-8","article-title":"Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407","volume":"31","author":"Newa","year":"2008","journal-title":"Arch. Pharm. Res."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518316182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518316182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T15:15:38Z","timestamp":1551712538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518316182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":30,"alternative-id":["S0731708518316182"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.12.018","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex-vivo intestinal absorption study of boswellic acid, cyclodextrin complexes and poloxamer solid dispersions using everted gut sac technique","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}